Peter Feinberg, Director at Immuneering Corp (IMRX), bought 9,500 shares at $24.45 ($232K) on 2021-09-20, disclosed to the SEC on 2021-09-21.
Open-market purchase of $232k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.45 | 4,750 | $116K | 50.0% |
| 2 | $24.45 | 4,750 | $116K | 50.0% |
| Total | $24.45 avg | 9,500 | $232K | 100% |
| Filing → |
| IMRX | BUY | 2025-10-01 | $53K | — | Filing → |
| IMRX | BUY | 2025-09-30 | $36K | — | Filing → |
| IMRX | BUY | 2025-06-23 | $127K | — | Filing → |